Another ECM molecule that modulates angiogenesis in the context of GI tumors is secreted protein acidic and rich in cysteine (SPARC)-like protein 1 (SPARCL1), a member of the SPARC family [142]. This evidence concerns the gene SPARCL1 and digestive system neoplasm.